| Criteria for Appropriateness (n = Applicable for Assessment) | n (%) |
| 1. Indications (39) | 39 (100) |
| 2. Choice of antifungal (39) | 38 (97.4) |
| 3. Dose of antifungal (37) | 37 (94.8) |
| 4. Microbiological appropriateness (18) | 18 (100) |
| 5. Intravenous-oral switch (11) | 7 (63.6) |
| 6. Treatment duration (21) | 19 (90.5) |